ImmunoGen

NASDAQ: IMGN
$5.93
+$0.20 (+3.5%)
Closing price September 21, 2021
ImmunoGen saw its shares make a sharp turn downward on Thursday morning after the stock has seen an incredible year of trading so far.
ImmunoGen announced this week that it has decided to partner with Jazz Pharmaceuticals, and investors have pushed Immunogen shares to a new 52-week high.
ImmunoGen has decided to partner with Jazz Pharmaceuticals for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate programs.
The top analyst upgrades, downgrades and other research calls from Thursday include AutoZone, O'Reilly Automotive, Immunogen, Medtronic, Nike, OncoSec Medical and Schlumberger.
The top analyst upgrades, downgrades and other research calls from Thursday include Amarin, American Express, Barrick Gold, Cameco, Groupon, ImmunoGen, JPMorgan and Whole Foods Market.
ImmunoGen watched its stock make a handy gain after the firm announced that had amended its license agreements with Sanofi.
October 14, 2016: Here are four stocks trading with relatively heavy volume among 57 equities making new 52-week lows in Friday’s session. On the NYSE, advancers led decliners by just better...
July 15, 2016: Here are four stocks trading with relatively heavy volume among just 11 equities making new 52-week lows in Friday’s session. Volumes only rose above 1 million for two of the...
July 14, 2016: Here are four stocks trading with relatively heavy volume among just 13 equities making new 52-week lows in Thursday’s session. Volumes did not rise about 1 million for any of...
July 13, 2016: Here are four stocks trading with relatively heavy volume among 11 equities making new 52-week lows in Wednesday’s session. NYSE decliners led advancers by a small margin and...
June 15, 2016: Here are four stocks trading with relatively heavy volume among 28 equities making new 52-week lows in Wednesday’s session. NYSE advancers led decliners by less than 2 to 1 while...
June 14, 2016: Here are four stocks trading with relatively heavy volume among 97 equities making new 52-week lows in Tuesday’s session. NYSE decliners led advancers by about 2 to 1 while...
The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society of Clinical Oncology (ASCO) is set to run from June 3 to June 7 in Chicago.
May 2, 2016: Here are four stocks trading with relatively heavy volume among 24 equities making new 52-week lows in Monday’s session. NYSE advancers led decliners by about 2 to 1 while Nasdaq...
April 29, 2016: Here are four stocks trading with relatively heavy volume among 28 equities making new 52-week lows in Friday’s session. NYSE decliners led advancers by about 5 to 4 while...